

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phenol-containing compound catabolic process (GO:0019336) | 7.75003521 |
| 2 | behavioral response to nicotine (GO:0035095) | 6.89296794 |
| 3 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 5.46454971 |
| 4 | vocalization behavior (GO:0071625) | 5.30775941 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.17776521 |
| 6 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 5.14512825 |
| 7 | lung lobe morphogenesis (GO:0060463) | 5.10854005 |
| 8 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.70470021 |
| 9 | L-amino acid import (GO:0043092) | 4.68971662 |
| 10 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.59698942 |
| 11 | sympathetic nervous system development (GO:0048485) | 4.58424904 |
| 12 | neuron cell-cell adhesion (GO:0007158) | 4.54806519 |
| 13 | behavioral response to ethanol (GO:0048149) | 4.49614160 |
| 14 | positive regulation of muscle hypertrophy (GO:0014742) | 4.44984425 |
| 15 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 4.44984425 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.41568765 |
| 17 | catecholamine transport (GO:0051937) | 4.36263526 |
| 18 | maternal behavior (GO:0042711) | 4.25131795 |
| 19 | dopamine biosynthetic process (GO:0042416) | 4.20724939 |
| 20 | prostate gland growth (GO:0060736) | 4.20451835 |
| 21 | negative regulation of neurotransmitter transport (GO:0051589) | 4.19988130 |
| 22 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.12746838 |
| 23 | protein localization to synapse (GO:0035418) | 4.07671894 |
| 24 | dopamine metabolic process (GO:0042417) | 3.98968890 |
| 25 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.98524142 |
| 26 | neurotransmitter secretion (GO:0007269) | 3.94211746 |
| 27 | catechol-containing compound biosynthetic process (GO:0009713) | 3.91816420 |
| 28 | catecholamine biosynthetic process (GO:0042423) | 3.91816420 |
| 29 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.89068649 |
| 30 | kynurenine metabolic process (GO:0070189) | 3.82640682 |
| 31 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.80617405 |
| 32 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.77209067 |
| 33 | glutamate secretion (GO:0014047) | 3.73445416 |
| 34 | neurotransmitter catabolic process (GO:0042135) | 3.69565801 |
| 35 | regulation of female receptivity (GO:0045924) | 3.69132681 |
| 36 | parental behavior (GO:0060746) | 3.68555837 |
| 37 | indole-containing compound catabolic process (GO:0042436) | 3.68497795 |
| 38 | indolalkylamine catabolic process (GO:0046218) | 3.68497795 |
| 39 | tryptophan catabolic process (GO:0006569) | 3.68497795 |
| 40 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.64860863 |
| 41 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 3.63744547 |
| 42 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.62882082 |
| 43 | C4-dicarboxylate transport (GO:0015740) | 3.53425638 |
| 44 | locomotory exploration behavior (GO:0035641) | 3.53195189 |
| 45 | response to pain (GO:0048265) | 3.48312855 |
| 46 | multicellular organismal reproductive behavior (GO:0033057) | 3.46675493 |
| 47 | neuron-neuron synaptic transmission (GO:0007270) | 3.46377481 |
| 48 | neurotransmitter biosynthetic process (GO:0042136) | 3.43282897 |
| 49 | presynaptic membrane assembly (GO:0097105) | 3.42945398 |
| 50 | lung vasculature development (GO:0060426) | 3.42366419 |
| 51 | synaptic transmission, cholinergic (GO:0007271) | 3.42030482 |
| 52 | regulation of synapse maturation (GO:0090128) | 3.41228360 |
| 53 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.41037398 |
| 54 | regulation of neurotransmitter secretion (GO:0046928) | 3.40818595 |
| 55 | detection of calcium ion (GO:0005513) | 3.40091072 |
| 56 | serotonin metabolic process (GO:0042428) | 3.37503419 |
| 57 | neuromuscular synaptic transmission (GO:0007274) | 3.35206389 |
| 58 | tryptophan metabolic process (GO:0006568) | 3.35159730 |
| 59 | neurotransmitter transport (GO:0006836) | 3.35143964 |
| 60 | positive regulation of synapse maturation (GO:0090129) | 3.32544538 |
| 61 | regulation of pigment cell differentiation (GO:0050932) | 3.31999105 |
| 62 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.31784924 |
| 63 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.30375305 |
| 64 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.30375305 |
| 65 | multi-organism reproductive behavior (GO:0044705) | 3.30065482 |
| 66 | regulation of respiratory gaseous exchange (GO:0043576) | 3.28895123 |
| 67 | synaptic transmission, dopaminergic (GO:0001963) | 3.28751927 |
| 68 | exploration behavior (GO:0035640) | 3.28130435 |
| 69 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.27937756 |
| 70 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.26012452 |
| 71 | prenylation (GO:0097354) | 3.25762580 |
| 72 | protein prenylation (GO:0018342) | 3.25762580 |
| 73 | norepinephrine metabolic process (GO:0042415) | 3.24415987 |
| 74 | amino acid import (GO:0043090) | 3.23465307 |
| 75 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.22283754 |
| 76 | positive regulation of glycolytic process (GO:0045821) | 3.21706667 |
| 77 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.20913362 |
| 78 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.19533845 |
| 79 | response to amphetamine (GO:0001975) | 3.18563790 |
| 80 | dopamine transport (GO:0015872) | 3.18333190 |
| 81 | regulation of neurotransmitter transport (GO:0051588) | 3.18307259 |
| 82 | cardiac chamber formation (GO:0003207) | 3.16491321 |
| 83 | proline transport (GO:0015824) | 3.16446914 |
| 84 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.16078105 |
| 85 | regulation of synaptic vesicle transport (GO:1902803) | 3.15791224 |
| 86 | exocrine pancreas development (GO:0031017) | 3.15601435 |
| 87 | startle response (GO:0001964) | 3.13763249 |
| 88 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.09898789 |
| 89 | regulation of vesicle fusion (GO:0031338) | 3.09294685 |
| 90 | reproductive behavior (GO:0019098) | 3.08888970 |
| 91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.08338824 |
| 92 | positive regulation of neurotransmitter transport (GO:0051590) | 3.07179337 |
| 93 | glutamate receptor signaling pathway (GO:0007215) | 3.07003188 |
| 94 | neuronal action potential propagation (GO:0019227) | 3.06369098 |
| 95 | presynaptic membrane organization (GO:0097090) | 3.05476580 |
| 96 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.05039140 |
| 97 | positive regulation of vesicle fusion (GO:0031340) | 3.04511572 |
| 98 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.04458474 |
| 99 | growth hormone receptor signaling pathway (GO:0060396) | 3.04169535 |
| 100 | sleep (GO:0030431) | 3.04049011 |
| 101 | postsynaptic membrane organization (GO:0001941) | 3.01853457 |
| 102 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.98787796 |
| 103 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.98710460 |
| 104 | regulation of neurotransmitter levels (GO:0001505) | 2.97215231 |
| 105 | female mating behavior (GO:0060180) | 2.97149009 |
| 106 | sodium ion export (GO:0071436) | 2.96966411 |
| 107 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.96788355 |
| 108 | gamma-aminobutyric acid transport (GO:0015812) | 2.96575996 |
| 109 | axon ensheathment in central nervous system (GO:0032291) | 2.95587758 |
| 110 | central nervous system myelination (GO:0022010) | 2.95587758 |
| 111 | acidic amino acid transport (GO:0015800) | 2.94865796 |
| 112 | primary amino compound metabolic process (GO:1901160) | 2.94660467 |
| 113 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.93903587 |
| 114 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.93903587 |
| 115 | cellular potassium ion homeostasis (GO:0030007) | 2.93710915 |
| 116 | indole-containing compound metabolic process (GO:0042430) | 2.93276106 |
| 117 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.93171655 |
| 118 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.92769640 |
| 119 | long-term memory (GO:0007616) | 2.92245404 |
| 120 | synaptic transmission, glutamatergic (GO:0035249) | 2.92173398 |
| 121 | synaptic vesicle endocytosis (GO:0048488) | 2.90267360 |
| 122 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.89677825 |
| 123 | regulation of synapse structural plasticity (GO:0051823) | 2.88207544 |
| 124 | synapse assembly (GO:0007416) | 2.88170303 |
| 125 | response to cocaine (GO:0042220) | 2.87709384 |
| 126 | mating behavior (GO:0007617) | 2.86740076 |
| 127 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.85273248 |
| 128 | regulation of postsynaptic membrane potential (GO:0060078) | 2.85034813 |
| 129 | mesonephros development (GO:0001823) | 2.84877456 |
| 130 | regulation of muscle adaptation (GO:0043502) | 2.83932238 |
| 131 | ovulation from ovarian follicle (GO:0001542) | 2.83573566 |
| 132 | catechol-containing compound metabolic process (GO:0009712) | 2.83052972 |
| 133 | catecholamine metabolic process (GO:0006584) | 2.83052972 |
| 134 | glycoprotein catabolic process (GO:0006516) | 2.82902241 |
| 135 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 2.82680155 |
| 136 | vesicle docking involved in exocytosis (GO:0006904) | 2.81552438 |
| 137 | synaptic vesicle maturation (GO:0016188) | 2.81272507 |
| 138 | response to histamine (GO:0034776) | 2.79737343 |
| 139 | regulation of muscle hypertrophy (GO:0014743) | 2.78204371 |
| 140 | L-glutamate transport (GO:0015813) | 2.78115146 |
| 141 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.78007379 |
| 142 | cellular response to growth hormone stimulus (GO:0071378) | 2.77952220 |
| 143 | transmission of nerve impulse (GO:0019226) | 2.77586745 |
| 144 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.77561562 |
| 145 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.76567218 |
| 146 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.74780175 |
| 147 | long-term synaptic potentiation (GO:0060291) | 2.73934827 |
| 148 | neuron recognition (GO:0008038) | 2.72456436 |
| 149 | behavioral response to cocaine (GO:0048148) | 2.72024072 |
| 150 | positive regulation of dendritic spine development (GO:0060999) | 2.71822423 |
| 151 | asymmetric protein localization (GO:0008105) | 2.71771193 |
| 152 | monoamine transport (GO:0015844) | 2.70957841 |
| 153 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.70701673 |
| 154 | cell migration in hindbrain (GO:0021535) | 2.70569074 |
| 155 | adult behavior (GO:0030534) | 2.70351792 |
| 156 | membrane depolarization during action potential (GO:0086010) | 2.70093170 |
| 157 | regulation of respiratory system process (GO:0044065) | 2.69656499 |
| 158 | cellular response to ammonium ion (GO:0071242) | 2.69578745 |
| 159 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.68345670 |
| 160 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.68180936 |
| 161 | cellular response to reactive nitrogen species (GO:1902170) | 2.64591897 |
| 162 | indolalkylamine metabolic process (GO:0006586) | 2.62713056 |
| 163 | retinal cone cell development (GO:0046549) | 2.60777125 |
| 164 | vesicle docking (GO:0048278) | 2.56877633 |
| 165 | negative regulation of metanephros development (GO:0072217) | 2.55221625 |
| 166 | aromatic amino acid family catabolic process (GO:0009074) | 2.54252864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.45823174 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.89076816 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 3.40263018 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.00023599 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.91941750 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.89561095 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.78657373 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71179882 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.64508995 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.55162513 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.49044299 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.44737648 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42651345 |
| 14 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.41059985 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37250795 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37250795 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35717425 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.28133347 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.22211450 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13720608 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.10339869 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06715180 |
| 23 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00854896 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96697453 |
| 25 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.95475958 |
| 26 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.94778404 |
| 27 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.94095970 |
| 28 | FUS_26573619_Chip-Seq_HEK293_Human | 1.92707823 |
| 29 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.91739123 |
| 30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91505376 |
| 31 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91475745 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87106564 |
| 33 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.85409364 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.84740163 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.83550229 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82845498 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76845462 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76081010 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.74817958 |
| 40 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.74484331 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.73651878 |
| 42 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.73295410 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.67813168 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.63333701 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.62657112 |
| 46 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.62246228 |
| 47 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.61574555 |
| 48 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.59075502 |
| 49 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58412698 |
| 50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.58059226 |
| 51 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.56940287 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.56440853 |
| 53 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.55630883 |
| 54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52718437 |
| 55 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50755313 |
| 56 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48592720 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.43745741 |
| 58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43262538 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42804718 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41533048 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.41515112 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.41515112 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40837205 |
| 64 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40772616 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39744325 |
| 66 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.39704935 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.38633257 |
| 68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.37777675 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.37555448 |
| 70 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.36000407 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.34775581 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32903147 |
| 73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32676819 |
| 74 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.32539690 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32024410 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30470507 |
| 77 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28922442 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27517397 |
| 79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26557034 |
| 80 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.25121070 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23606476 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23149802 |
| 83 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22941330 |
| 84 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22761979 |
| 85 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21981528 |
| 86 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.21879451 |
| 87 | JUN_21703547_ChIP-Seq_K562_Human | 1.20788139 |
| 88 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.19621049 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18698827 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18341485 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.18032776 |
| 92 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.17749636 |
| 93 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17344880 |
| 94 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16538504 |
| 95 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.16276727 |
| 96 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13822064 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13475430 |
| 98 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13078706 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.12947048 |
| 100 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12704993 |
| 101 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12035511 |
| 102 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.10582510 |
| 103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10449188 |
| 104 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09788615 |
| 105 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.09127800 |
| 106 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08823885 |
| 107 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08613253 |
| 108 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.08406867 |
| 109 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08391832 |
| 110 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08164390 |
| 111 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06498762 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.06116104 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05115654 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04122114 |
| 115 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03603036 |
| 116 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.03477190 |
| 117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03239065 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02715830 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.02582025 |
| 120 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.02582025 |
| 121 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02357399 |
| 122 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02143038 |
| 123 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.01511632 |
| 124 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01173996 |
| 125 | * AR_19668381_ChIP-Seq_PC3_Human | 1.00600814 |
| 126 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00307446 |
| 127 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.00258628 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98778708 |
| 129 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98400620 |
| 130 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98143672 |
| 131 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96003934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002822_catalepsy | 6.21720124 |
| 2 | MP0008004_abnormal_stomach_pH | 4.39892141 |
| 3 | MP0010386_abnormal_urinary_bladder | 4.29513688 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.49647747 |
| 5 | MP0009745_abnormal_behavioral_response | 3.31260541 |
| 6 | MP0002638_abnormal_pupillary_reflex | 3.15164541 |
| 7 | MP0003635_abnormal_synaptic_transmissio | 3.05345434 |
| 8 | MP0001501_abnormal_sleep_pattern | 2.75313432 |
| 9 | MP0001905_abnormal_dopamine_level | 2.71482247 |
| 10 | MP0009046_muscle_twitch | 2.60406758 |
| 11 | MP0002064_seizures | 2.57687684 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.54111115 |
| 13 | MP0002063_abnormal_learning/memory/cond | 2.53205405 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.51667014 |
| 15 | MP0003880_abnormal_central_pattern | 2.50033585 |
| 16 | MP0006276_abnormal_autonomic_nervous | 2.49014662 |
| 17 | MP0004270_analgesia | 2.47255659 |
| 18 | MP0001188_hyperpigmentation | 2.45901727 |
| 19 | MP0005646_abnormal_pituitary_gland | 2.41892809 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.40083958 |
| 21 | MP0001968_abnormal_touch/_nociception | 2.20704343 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.19427406 |
| 23 | MP0002272_abnormal_nervous_system | 2.10915549 |
| 24 | MP0001529_abnormal_vocalization | 2.00736291 |
| 25 | MP0001970_abnormal_pain_threshold | 1.98269880 |
| 26 | MP0003724_increased_susceptibility_to | 1.92526277 |
| 27 | MP0004924_abnormal_behavior | 1.90984886 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.90984886 |
| 29 | MP0006054_spinal_hemorrhage | 1.90357770 |
| 30 | MP0003941_abnormal_skin_development | 1.89115251 |
| 31 | MP0002733_abnormal_thermal_nociception | 1.85990178 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.75527475 |
| 33 | MP0001486_abnormal_startle_reflex | 1.74821855 |
| 34 | MP0002736_abnormal_nociception_after | 1.74523116 |
| 35 | MP0003787_abnormal_imprinting | 1.71586840 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.69867097 |
| 37 | MP0000383_abnormal_hair_follicle | 1.68209922 |
| 38 | MP0005171_absent_coat_pigmentation | 1.65662449 |
| 39 | MP0003122_maternal_imprinting | 1.64874554 |
| 40 | MP0000538_abnormal_urinary_bladder | 1.63407099 |
| 41 | MP0002557_abnormal_social/conspecific_i | 1.59595534 |
| 42 | MP0002184_abnormal_innervation | 1.59424967 |
| 43 | MP0001542_abnormal_bone_strength | 1.51089531 |
| 44 | MP0001984_abnormal_olfaction | 1.51060999 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.50180032 |
| 46 | MP0008569_lethality_at_weaning | 1.50004671 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.43240526 |
| 48 | MP0004858_abnormal_nervous_system | 1.42272754 |
| 49 | MP0000920_abnormal_myelination | 1.41460438 |
| 50 | MP0008872_abnormal_physiological_respon | 1.40887593 |
| 51 | MP0003638_abnormal_response/metabolism_ | 1.36895575 |
| 52 | MP0002876_abnormal_thyroid_physiology | 1.35489552 |
| 53 | MP0003690_abnormal_glial_cell | 1.34381502 |
| 54 | MP0005423_abnormal_somatic_nervous | 1.34136081 |
| 55 | MP0005409_darkened_coat_color | 1.33031980 |
| 56 | MP0004130_abnormal_muscle_cell | 1.30801605 |
| 57 | MP0004085_abnormal_heartbeat | 1.29684574 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.27218535 |
| 59 | MP0003938_abnormal_ear_development | 1.26920737 |
| 60 | MP0000604_amyloidosis | 1.26627544 |
| 61 | MP0000778_abnormal_nervous_system | 1.24876078 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.23122868 |
| 63 | MP0002138_abnormal_hepatobiliary_system | 1.20880231 |
| 64 | MP0002163_abnormal_gland_morphology | 1.17905056 |
| 65 | MP0000372_irregular_coat_pigmentation | 1.16569310 |
| 66 | MP0004484_altered_response_of | 1.16319555 |
| 67 | MP0003183_abnormal_peptide_metabolism | 1.16022656 |
| 68 | MP0003879_abnormal_hair_cell | 1.14533671 |
| 69 | MP0002751_abnormal_autonomic_nervous | 1.13888754 |
| 70 | MP0000013_abnormal_adipose_tissue | 1.10227342 |
| 71 | MP0001502_abnormal_circadian_rhythm | 1.09000223 |
| 72 | MP0000569_abnormal_digit_pigmentation | 1.07875523 |
| 73 | MP0005503_abnormal_tendon_morphology | 1.06582612 |
| 74 | MP0004215_abnormal_myocardial_fiber | 1.04320192 |
| 75 | MP0000465_gastrointestinal_hemorrhage | 1.03567100 |
| 76 | MP0002066_abnormal_motor_capabilities/c | 0.99936167 |
| 77 | MP0001177_atelectasis | 0.98723989 |
| 78 | MP0002127_abnormal_cardiovascular_syste | 0.97688875 |
| 79 | MP0002909_abnormal_adrenal_gland | 0.97465361 |
| 80 | MP0003631_nervous_system_phenotype | 0.97423215 |
| 81 | MP0004147_increased_porphyrin_level | 0.95883807 |
| 82 | MP0001919_abnormal_reproductive_system | 0.95853170 |
| 83 | MP0000230_abnormal_systemic_arterial | 0.95458708 |
| 84 | MP0004811_abnormal_neuron_physiology | 0.94999486 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 0.94436567 |
| 86 | MP0003633_abnormal_nervous_system | 0.93967755 |
| 87 | * MP0005389_reproductive_system_phenotype | 0.93470247 |
| 88 | MP0002229_neurodegeneration | 0.90431624 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.89795146 |
| 90 | MP0002882_abnormal_neuron_morphology | 0.88718157 |
| 91 | MP0003075_altered_response_to | 0.88562357 |
| 92 | MP0000751_myopathy | 0.87703306 |
| 93 | MP0001835_abnormal_antigen_presentation | 0.87301886 |
| 94 | MP0010678_abnormal_skin_adnexa | 0.86071167 |
| 95 | MP0005620_abnormal_muscle_contractility | 0.85568230 |
| 96 | MP0001851_eye_inflammation | 0.83810234 |
| 97 | * MP0002160_abnormal_reproductive_system | 0.82064291 |
| 98 | MP0002972_abnormal_cardiac_muscle | 0.81522022 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.81481733 |
| 100 | MP0003329_amyloid_beta_deposits | 0.80499847 |
| 101 | MP0003436_decreased_susceptibility_to | 0.79923241 |
| 102 | MP0008874_decreased_physiological_sensi | 0.79689445 |
| 103 | MP0000955_abnormal_spinal_cord | 0.79126197 |
| 104 | MP0003632_abnormal_nervous_system | 0.77889563 |
| 105 | MP0001765_abnormal_ion_homeostasis | 0.77386832 |
| 106 | MP0001986_abnormal_taste_sensitivity | 0.75927745 |
| 107 | MP0001664_abnormal_digestion | 0.74678202 |
| 108 | MP0004883_abnormal_blood_vessel | 0.73522153 |
| 109 | MP0004742_abnormal_vestibular_system | 0.73394421 |
| 110 | MP0005394_taste/olfaction_phenotype | 0.72971039 |
| 111 | MP0005499_abnormal_olfactory_system | 0.72971039 |
| 112 | MP0002102_abnormal_ear_morphology | 0.72127199 |
| 113 | MP0002069_abnormal_eating/drinking_beha | 0.71717191 |
| 114 | MP0000681_abnormal_thyroid_gland | 0.70494623 |
| 115 | MP0001963_abnormal_hearing_physiology | 0.70146895 |
| 116 | MP0005535_abnormal_body_temperature | 0.69848856 |
| 117 | MP0003121_genomic_imprinting | 0.68674734 |
| 118 | MP0001270_distended_abdomen | 0.68383626 |
| 119 | MP0000049_abnormal_middle_ear | 0.68272840 |
| 120 | MP0002108_abnormal_muscle_morphology | 0.68241149 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.67491757 |
| 122 | MP0005595_abnormal_vascular_smooth | 0.66928654 |
| 123 | MP0001533_abnormal_skeleton_physiology | 0.66810698 |
| 124 | MP0000631_abnormal_neuroendocrine_gland | 0.66541273 |
| 125 | MP0008438_abnormal_cutaneous_collagen | 0.66424691 |
| 126 | MP0006138_congestive_heart_failure | 0.66349198 |
| 127 | MP0000516_abnormal_urinary_system | 0.65807464 |
| 128 | MP0005367_renal/urinary_system_phenotyp | 0.65807464 |
| 129 | MP0002152_abnormal_brain_morphology | 0.65473863 |
| 130 | MP0002254_reproductive_system_inflammat | 0.64538495 |
| 131 | MP0002090_abnormal_vision | 0.62847214 |
| 132 | MP0005197_abnormal_uvea_morphology | 0.62071142 |
| 133 | MP0004885_abnormal_endolymph | 0.61622072 |
| 134 | MP0004142_abnormal_muscle_tone | 0.61370389 |
| 135 | MP0003045_fibrosis | 0.60732260 |
| 136 | MP0003279_aneurysm | 0.60726109 |
| 137 | MP0000427_abnormal_hair_cycle | 0.60093239 |
| 138 | MP0005508_abnormal_skeleton_morphology | 0.59988769 |
| 139 | MP0003634_abnormal_glial_cell | 0.59354817 |
| 140 | MP0001958_emphysema | 0.57217470 |
| 141 | MP0005390_skeleton_phenotype | 0.51642395 |
| 142 | MP0002928_abnormal_bile_duct | 0.51506810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypothermia (HP:0002045) | 8.37489394 |
| 2 | Focal motor seizures (HP:0011153) | 7.90907318 |
| 3 | Febrile seizures (HP:0002373) | 5.88815860 |
| 4 | Neonatal short-limb short stature (HP:0008921) | 5.16324521 |
| 5 | Atonic seizures (HP:0010819) | 4.85145176 |
| 6 | Myokymia (HP:0002411) | 4.70661390 |
| 7 | Focal seizures (HP:0007359) | 4.69692023 |
| 8 | Hyperventilation (HP:0002883) | 4.68131673 |
| 9 | Epileptic encephalopathy (HP:0200134) | 4.54601090 |
| 10 | Orthostatic hypotension (HP:0001278) | 4.38564658 |
| 11 | Flat capital femoral epiphysis (HP:0003370) | 4.25303795 |
| 12 | Neonatal hypoglycemia (HP:0001998) | 4.23628231 |
| 13 | Limb dystonia (HP:0002451) | 4.20477870 |
| 14 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.87680411 |
| 15 | Type 2 muscle fiber atrophy (HP:0003554) | 3.80721244 |
| 16 | Amblyopia (HP:0000646) | 3.75887272 |
| 17 | Progressive cerebellar ataxia (HP:0002073) | 3.71196644 |
| 18 | Scanning speech (HP:0002168) | 3.49606406 |
| 19 | Visual hallucinations (HP:0002367) | 3.38146671 |
| 20 | Absence seizures (HP:0002121) | 3.33778501 |
| 21 | Large earlobe (HP:0009748) | 3.32523305 |
| 22 | Exotropia (HP:0000577) | 3.27730918 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 3.21325536 |
| 24 | Ankle clonus (HP:0011448) | 3.13878439 |
| 25 | Dialeptic seizures (HP:0011146) | 3.11639436 |
| 26 | Hypoplastic left heart (HP:0004383) | 3.08872176 |
| 27 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.04614532 |
| 28 | Progressive inability to walk (HP:0002505) | 2.97523654 |
| 29 | Muscle fiber atrophy (HP:0100295) | 2.95700314 |
| 30 | Torticollis (HP:0000473) | 2.95005246 |
| 31 | Spinal cord compression (HP:0002176) | 2.93713878 |
| 32 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.88542936 |
| 33 | Abnormal drinking behavior (HP:0030082) | 2.88309970 |
| 34 | Polydipsia (HP:0001959) | 2.88309970 |
| 35 | Hyperthyroidism (HP:0000836) | 2.87182799 |
| 36 | Inability to walk (HP:0002540) | 2.85828339 |
| 37 | Protruding tongue (HP:0010808) | 2.81384104 |
| 38 | Abnormal hair whorl (HP:0010721) | 2.78271404 |
| 39 | Hip contracture (HP:0003273) | 2.76144447 |
| 40 | Hypoplastic heart (HP:0001961) | 2.70229702 |
| 41 | Irregular epiphyses (HP:0010582) | 2.67137808 |
| 42 | Flattened epiphyses (HP:0003071) | 2.66833588 |
| 43 | Stomach cancer (HP:0012126) | 2.65614875 |
| 44 | Postural instability (HP:0002172) | 2.64187892 |
| 45 | Spastic gait (HP:0002064) | 2.62768104 |
| 46 | Broad-based gait (HP:0002136) | 2.61294501 |
| 47 | Supranuclear gaze palsy (HP:0000605) | 2.60746844 |
| 48 | Hypoplasia of the iris (HP:0007676) | 2.60484111 |
| 49 | Hypomagnesemia (HP:0002917) | 2.59330073 |
| 50 | Glucose intolerance (HP:0000833) | 2.58565145 |
| 51 | Breech presentation (HP:0001623) | 2.58193303 |
| 52 | Papilledema (HP:0001085) | 2.57150901 |
| 53 | Absent speech (HP:0001344) | 2.56300089 |
| 54 | Visceral angiomatosis (HP:0100761) | 2.52749548 |
| 55 | Flat acetabular roof (HP:0003180) | 2.50210341 |
| 56 | Gaze-evoked nystagmus (HP:0000640) | 2.49891163 |
| 57 | Enlarged epiphyses (HP:0010580) | 2.49521058 |
| 58 | Poor eye contact (HP:0000817) | 2.46223220 |
| 59 | Genetic anticipation (HP:0003743) | 2.45629530 |
| 60 | Abnormal eating behavior (HP:0100738) | 2.42451014 |
| 61 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.41054293 |
| 62 | Agammaglobulinemia (HP:0004432) | 2.40818731 |
| 63 | Hip dysplasia (HP:0001385) | 2.40217873 |
| 64 | Retinal dysplasia (HP:0007973) | 2.39308488 |
| 65 | Gait imbalance (HP:0002141) | 2.35846548 |
| 66 | Fetal akinesia sequence (HP:0001989) | 2.35390037 |
| 67 | Abnormal social behavior (HP:0012433) | 2.32735648 |
| 68 | Impaired social interactions (HP:0000735) | 2.32735648 |
| 69 | Bradycardia (HP:0001662) | 2.30019515 |
| 70 | Autoimmune hemolytic anemia (HP:0001890) | 2.29914623 |
| 71 | Hoarse voice (HP:0001609) | 2.28339289 |
| 72 | Hemangiomatosis (HP:0007461) | 2.28314308 |
| 73 | Blue irides (HP:0000635) | 2.28036502 |
| 74 | Syncope (HP:0001279) | 2.25197994 |
| 75 | Abnormality of B cell number (HP:0010975) | 2.22344960 |
| 76 | Clumsiness (HP:0002312) | 2.22097670 |
| 77 | Medial flaring of the eyebrow (HP:0010747) | 2.22029922 |
| 78 | Diplopia (HP:0000651) | 2.21868886 |
| 79 | Abnormality of binocular vision (HP:0011514) | 2.21868886 |
| 80 | Clonus (HP:0002169) | 2.21338747 |
| 81 | Limited hip movement (HP:0008800) | 2.20228435 |
| 82 | Bundle branch block (HP:0011710) | 2.19350511 |
| 83 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.18111013 |
| 84 | Abnormal cartilage morphology (HP:0002763) | 2.17452770 |
| 85 | Pheochromocytoma (HP:0002666) | 2.15346669 |
| 86 | Nephrogenic diabetes insipidus (HP:0009806) | 2.14810531 |
| 87 | Anxiety (HP:0000739) | 2.14222532 |
| 88 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.13836177 |
| 89 | Hypoventilation (HP:0002791) | 2.12737000 |
| 90 | Polyuria (HP:0000103) | 2.11075870 |
| 91 | Chin dimple (HP:0010751) | 2.10860664 |
| 92 | Congenital primary aphakia (HP:0007707) | 2.10683370 |
| 93 | Autoimmune thrombocytopenia (HP:0001973) | 2.09776653 |
| 94 | Eosinophilia (HP:0001880) | 2.09363200 |
| 95 | Genital tract atresia (HP:0001827) | 2.08665510 |
| 96 | Amelogenesis imperfecta (HP:0000705) | 2.07249882 |
| 97 | Hemiplegia (HP:0002301) | 2.06393725 |
| 98 | Atrial fibrillation (HP:0005110) | 2.05863535 |
| 99 | Primary atrial arrhythmia (HP:0001692) | 2.05800770 |
| 100 | Neuroendocrine neoplasm (HP:0100634) | 2.05331245 |
| 101 | Absent eyebrow (HP:0002223) | 2.05097878 |
| 102 | Generalized hypopigmentation of hair (HP:0011358) | 2.04974334 |
| 103 | Drooling (HP:0002307) | 2.04251932 |
| 104 | Excessive salivation (HP:0003781) | 2.04251932 |
| 105 | Abnormality of the corticospinal tract (HP:0002492) | 2.01925745 |
| 106 | Atrioventricular canal defect (HP:0006695) | 2.01307955 |
| 107 | Acute necrotizing encephalopathy (HP:0006965) | 2.01222014 |
| 108 | Tetany (HP:0001281) | 2.01050349 |
| 109 | Fair hair (HP:0002286) | 1.97361099 |
| 110 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.96311139 |
| 111 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.96311139 |
| 112 | Agitation (HP:0000713) | 1.95447111 |
| 113 | Weak cry (HP:0001612) | 1.95151473 |
| 114 | Mitral stenosis (HP:0001718) | 1.94249555 |
| 115 | Patent foramen ovale (HP:0001655) | 1.92521712 |
| 116 | Recurrent corneal erosions (HP:0000495) | 1.92517241 |
| 117 | Arterial tortuosity (HP:0005116) | 1.92442138 |
| 118 | Abnormality of incisor morphology (HP:0011063) | 1.92081293 |
| 119 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.91998801 |
| 120 | Progressive macrocephaly (HP:0004481) | 1.90819743 |
| 121 | Abnormality of salivation (HP:0100755) | 1.90694375 |
| 122 | Abnormality of the prostate (HP:0008775) | 1.90678796 |
| 123 | Narrow nasal bridge (HP:0000446) | 1.90635338 |
| 124 | Impaired vibratory sensation (HP:0002495) | 1.89215919 |
| 125 | Focal dystonia (HP:0004373) | 1.89151712 |
| 126 | Supraventricular tachycardia (HP:0004755) | 1.89122389 |
| 127 | Neoplasm of head and neck (HP:0012288) | 1.88523166 |
| 128 | Esophageal neoplasm (HP:0100751) | 1.88523166 |
| 129 | Dysmetric saccades (HP:0000641) | 1.88504120 |
| 130 | Epileptiform EEG discharges (HP:0011182) | 1.87416979 |
| 131 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.84940989 |
| 132 | Lower limb muscle weakness (HP:0007340) | 1.84596266 |
| 133 | Polyphagia (HP:0002591) | 1.84216696 |
| 134 | B lymphocytopenia (HP:0010976) | 1.83763867 |
| 135 | Vascular tortuosity (HP:0004948) | 1.83652159 |
| 136 | Decreased muscle mass (HP:0003199) | 1.83543450 |
| 137 | Myotonia (HP:0002486) | 1.83003021 |
| 138 | Craniofacial dystonia (HP:0012179) | 1.82818861 |
| 139 | Vaginal atresia (HP:0000148) | 1.82130763 |
| 140 | Abnormal glucose tolerance (HP:0001952) | 1.82115079 |
| 141 | Abnormality of magnesium homeostasis (HP:0004921) | 1.81544817 |
| 142 | Slow saccadic eye movements (HP:0000514) | 1.81017750 |
| 143 | Status epilepticus (HP:0002133) | 1.80948075 |
| 144 | Aplasia involving bones of the extremities (HP:0009825) | 1.80733919 |
| 145 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.80733919 |
| 146 | Aplasia of the phalanges of the hand (HP:0009802) | 1.80733919 |
| 147 | Supraventricular arrhythmia (HP:0005115) | 1.80593291 |
| 148 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80394976 |
| 149 | Hyperaldosteronism (HP:0000859) | 1.80249539 |
| 150 | Increased corneal curvature (HP:0100692) | 1.80233127 |
| 151 | Keratoconus (HP:0000563) | 1.80233127 |
| 152 | Mesangial abnormality (HP:0001966) | 1.78640199 |
| 153 | Prolonged QT interval (HP:0001657) | 1.78372941 |
| 154 | Cubitus valgus (HP:0002967) | 1.78288396 |
| 155 | Abnormality of renin-angiotensin system (HP:0000847) | 1.78213072 |
| 156 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.77437866 |
| 157 | Autoamputation (HP:0001218) | 1.76340534 |
| 158 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.76210023 |
| 159 | Decreased circulating renin level (HP:0003351) | 1.75830350 |
| 160 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.75628899 |
| 161 | Failure to thrive in infancy (HP:0001531) | 1.75284210 |
| 162 | Action tremor (HP:0002345) | 1.75073724 |
| 163 | Truncal ataxia (HP:0002078) | 1.74825714 |
| 164 | Aplasia of the musculature (HP:0100854) | 1.74553970 |
| 165 | Thyroid carcinoma (HP:0002890) | 1.74521172 |
| 166 | Gastroesophageal reflux (HP:0002020) | 1.73829393 |
| 167 | Ventricular fibrillation (HP:0001663) | 1.73020860 |
| 168 | Decreased central vision (HP:0007663) | 1.72347322 |
| 169 | Lissencephaly (HP:0001339) | 1.71834464 |
| 170 | Urethral obstruction (HP:0000796) | 1.71764473 |
| 171 | Abnormality of dental color (HP:0011073) | 1.67901179 |
| 172 | Dysautonomia (HP:0002459) | 1.64814565 |
| 173 | Thyroid-stimulating hormone excess (HP:0002925) | 1.64653836 |
| 174 | Pancreatic fibrosis (HP:0100732) | 1.64412094 |
| 175 | Xerostomia (HP:0000217) | 1.63579261 |
| 176 | Complete atrioventricular canal defect (HP:0001674) | 1.63414643 |
| 177 | Hypotension (HP:0002615) | 1.62437895 |
| 178 | Hypsarrhythmia (HP:0002521) | 1.61870496 |
| 179 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.59472055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.34052645 |
| 2 | MAP2K7 | 3.74958530 |
| 3 | CASK | 3.43147259 |
| 4 | NTRK3 | 3.40914215 |
| 5 | PDK2 | 3.37247889 |
| 6 | NTRK1 | 3.27095844 |
| 7 | MAP3K12 | 3.23454269 |
| 8 | MAP3K4 | 3.06613399 |
| 9 | GRK7 | 2.81529530 |
| 10 | AKT3 | 2.67890744 |
| 11 | GRK5 | 2.43767393 |
| 12 | MYLK | 2.21379577 |
| 13 | NLK | 2.15538701 |
| 14 | JAK1 | 2.07501495 |
| 15 | PLK2 | 2.04933396 |
| 16 | CSNK1G1 | 1.94864477 |
| 17 | SIK3 | 1.90110482 |
| 18 | MAP2K4 | 1.87137145 |
| 19 | KIT | 1.85265307 |
| 20 | MAP4K2 | 1.83455902 |
| 21 | EPHA4 | 1.81006445 |
| 22 | MINK1 | 1.74426968 |
| 23 | RIPK4 | 1.70580264 |
| 24 | TNIK | 1.67535443 |
| 25 | MAPK13 | 1.64832654 |
| 26 | INSRR | 1.62744961 |
| 27 | MARK1 | 1.60233995 |
| 28 | PRPF4B | 1.55847460 |
| 29 | DAPK2 | 1.50680736 |
| 30 | BMPR2 | 1.49395033 |
| 31 | PRKCE | 1.46531792 |
| 32 | PNCK | 1.44621939 |
| 33 | PDGFRA | 1.39379049 |
| 34 | SGK2 | 1.37231848 |
| 35 | TEC | 1.33618595 |
| 36 | CAMK4 | 1.26716848 |
| 37 | MAP3K6 | 1.22250240 |
| 38 | PDGFRB | 1.21890857 |
| 39 | CAMKK2 | 1.20931663 |
| 40 | MAPKAPK5 | 1.18536766 |
| 41 | MATK | 1.18110878 |
| 42 | SIK2 | 1.17693665 |
| 43 | ADRBK2 | 1.17506333 |
| 44 | CDK19 | 1.16544780 |
| 45 | NTRK2 | 1.14290341 |
| 46 | DAPK1 | 1.12569207 |
| 47 | ZAK | 1.11142542 |
| 48 | PDK1 | 1.10971684 |
| 49 | SGK223 | 1.10574074 |
| 50 | SGK494 | 1.10574074 |
| 51 | PIK3CG | 1.08942088 |
| 52 | YES1 | 1.07822714 |
| 53 | PTK2B | 1.06570172 |
| 54 | JAK2 | 1.03545177 |
| 55 | ADRBK1 | 1.00987654 |
| 56 | ERBB4 | 0.99804134 |
| 57 | MUSK | 0.98434446 |
| 58 | PRKCG | 0.97872418 |
| 59 | MAP3K9 | 0.96693316 |
| 60 | PDPK1 | 0.96442023 |
| 61 | OBSCN | 0.95596374 |
| 62 | CAMK2A | 0.93025234 |
| 63 | TRPM7 | 0.89276457 |
| 64 | STK24 | 0.88826204 |
| 65 | CSNK1G2 | 0.87591937 |
| 66 | DYRK1A | 0.87068931 |
| 67 | STK11 | 0.86927115 |
| 68 | BMPR1B | 0.86828444 |
| 69 | CDK5 | 0.86288022 |
| 70 | TSSK6 | 0.83289318 |
| 71 | MAP2K6 | 0.82156591 |
| 72 | RET | 0.79050983 |
| 73 | UHMK1 | 0.77808714 |
| 74 | CAMK1 | 0.76812512 |
| 75 | SGK3 | 0.73812745 |
| 76 | PIK3CA | 0.73046635 |
| 77 | SYK | 0.72329989 |
| 78 | NEK6 | 0.71593365 |
| 79 | MARK2 | 0.71538913 |
| 80 | MAP3K7 | 0.71530987 |
| 81 | CAMKK1 | 0.71175609 |
| 82 | FRK | 0.69949346 |
| 83 | OXSR1 | 0.68559102 |
| 84 | FGR | 0.68552040 |
| 85 | MAP2K1 | 0.68037866 |
| 86 | CDC42BPA | 0.67853166 |
| 87 | CAMK2B | 0.67599542 |
| 88 | WNK1 | 0.67516834 |
| 89 | CDK8 | 0.67070684 |
| 90 | MAP3K14 | 0.66463730 |
| 91 | ARAF | 0.65086197 |
| 92 | FES | 0.62769064 |
| 93 | CAMK2D | 0.59662885 |
| 94 | LATS2 | 0.59388116 |
| 95 | MAPKAPK3 | 0.58723845 |
| 96 | CSNK1G3 | 0.58578025 |
| 97 | CSNK1D | 0.57360120 |
| 98 | MAP3K2 | 0.56836459 |
| 99 | NME1 | 0.55551449 |
| 100 | PRKCQ | 0.54843242 |
| 101 | MAP3K13 | 0.54663057 |
| 102 | PRKCA | 0.53582279 |
| 103 | SGK1 | 0.52891319 |
| 104 | GRK6 | 0.52229771 |
| 105 | PRKD3 | 0.51771955 |
| 106 | ERBB3 | 0.51476451 |
| 107 | FGFR2 | 0.51121072 |
| 108 | CSNK1A1 | 0.49605668 |
| 109 | PRKD1 | 0.49360950 |
| 110 | CAMK2G | 0.48480237 |
| 111 | GRK1 | 0.48391265 |
| 112 | MELK | 0.47301163 |
| 113 | CCNB1 | 0.47193524 |
| 114 | CDK3 | 0.46863792 |
| 115 | EEF2K | 0.46534915 |
| 116 | RPS6KA6 | 0.45693207 |
| 117 | BCR | 0.45497415 |
| 118 | MAPK15 | 0.45354800 |
| 119 | RPS6KA3 | 0.44962468 |
| 120 | PAK6 | 0.41827742 |
| 121 | MAP3K5 | 0.41478460 |
| 122 | PRKG1 | 0.41277880 |
| 123 | PRKACA | 0.40952377 |
| 124 | PRKCH | 0.40513955 |
| 125 | RPS6KA2 | 0.39943176 |
| 126 | MAPK12 | 0.39907820 |
| 127 | CDK18 | 0.39703975 |
| 128 | PLK3 | 0.39519021 |
| 129 | STK38 | 0.39517823 |
| 130 | MKNK1 | 0.39325904 |
| 131 | KSR1 | 0.39319502 |
| 132 | ALK | 0.37687794 |
| 133 | FER | 0.36741636 |
| 134 | SCYL2 | 0.36610211 |
| 135 | KSR2 | 0.36208765 |
| 136 | PHKG2 | 0.35752747 |
| 137 | PHKG1 | 0.35752747 |
| 138 | PINK1 | 0.35085189 |
| 139 | PKN1 | 0.34776102 |
| 140 | PRKCB | 0.34753189 |
| 141 | MAPK7 | 0.34611640 |
| 142 | BRAF | 0.34158190 |
| 143 | TIE1 | 0.33652424 |
| 144 | PAK3 | 0.33636692 |
| 145 | CDK14 | 0.33585946 |
| 146 | DAPK3 | 0.33463496 |
| 147 | ABL2 | 0.32701626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 4.90403654 |
| 2 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 3.56614099 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.49921250 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.34669510 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.68608291 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.62300198 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.59839646 |
| 8 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.49804029 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.43486189 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.34921136 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 2.29680769 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 2.26389672 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.19925675 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 2.15379745 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12339457 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.11217732 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.07896904 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 2.01069029 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.88057108 |
| 20 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.86295804 |
| 21 | Long-term potentiation_Homo sapiens_hsa04720 | 1.83893745 |
| 22 | Salivary secretion_Homo sapiens_hsa04970 | 1.78239922 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.78035979 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.77825508 |
| 25 | Insulin secretion_Homo sapiens_hsa04911 | 1.70772827 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.67153923 |
| 27 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61719484 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56193971 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.55524922 |
| 30 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50655778 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.46370486 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.43814019 |
| 33 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.40482960 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.39308149 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.38986521 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.38864544 |
| 37 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36753610 |
| 38 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34817106 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34653044 |
| 40 | Alzheimers disease_Homo sapiens_hsa05010 | 1.32409663 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31623718 |
| 42 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31097881 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31015045 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.26505308 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23079598 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.22344790 |
| 47 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.21415226 |
| 48 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.16578406 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.15338400 |
| 50 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.09098910 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08889494 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.03366450 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.02087070 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01323949 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99866850 |
| 56 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91373851 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.87435879 |
| 58 | Huntingtons disease_Homo sapiens_hsa05016 | 0.85726852 |
| 59 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82924564 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82148368 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81129254 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.77401522 |
| 63 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77128418 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77020827 |
| 65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.76649761 |
| 66 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76103831 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.75516938 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.74968857 |
| 69 | Melanogenesis_Homo sapiens_hsa04916 | 0.74585751 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73302298 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72801172 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70743529 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68758132 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.68326018 |
| 75 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68191836 |
| 76 | Phototransduction_Homo sapiens_hsa04744 | 0.66859927 |
| 77 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66090724 |
| 78 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66005268 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.64292667 |
| 80 | Circadian rhythm_Homo sapiens_hsa04710 | 0.63281666 |
| 81 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63275343 |
| 82 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62029295 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61853180 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59192743 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57549339 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56952412 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54464444 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52369456 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49760295 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49439739 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48523114 |
| 92 | Glioma_Homo sapiens_hsa05214 | 0.48194062 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47977167 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47664858 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47179084 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44882065 |
| 97 | Alcoholism_Homo sapiens_hsa05034 | 0.43621330 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43521149 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43049321 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42831343 |
| 101 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42241776 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42040538 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41396685 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.40795221 |
| 105 | Melanoma_Homo sapiens_hsa05218 | 0.40670751 |
| 106 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.38711441 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36944853 |
| 108 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35512465 |
| 109 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.35254625 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35002747 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33306227 |
| 112 | Purine metabolism_Homo sapiens_hsa00230 | 0.32715347 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32436118 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.32314746 |
| 115 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31210463 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.30966139 |
| 117 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.30838993 |
| 118 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.30226640 |
| 119 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.29880782 |
| 120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.28066710 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27751810 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27716857 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.27315854 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24757971 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.24499707 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.19673273 |
| 127 | Tuberculosis_Homo sapiens_hsa05152 | 0.19427622 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.19282906 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19261112 |
| 130 | Amoebiasis_Homo sapiens_hsa05146 | 0.17744626 |
| 131 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.14421094 |
| 132 | Pertussis_Homo sapiens_hsa05133 | 0.12763052 |
| 133 | Allograft rejection_Homo sapiens_hsa05330 | 0.12574038 |

